2025年COVID-19唾液筛检检测市场潜力全球报告

预计未来几年 COVID-19 唾液筛检测试的潜在市场规模将强劲成长。到 2029 年，这一数字将成长至 61.7 亿美元，年复合成长率（CAGR）为 9.5%。预测期内的成长可归因于筛检计画的整合、监管支持、对快速 COVID-19照护现场的需求不断增长、人口增长以及电子商务的兴起等。预测期内的关键趋势包括非医疗环境中的采用率不断提高、与数位健康平台的整合、下一代技术的出现、技术进步和策略伙伴关係。

预计未来几年医疗保健支出的增加将推动 COVID-19 唾液筛检测试市场的扩张。医疗保健支出包括所有与医疗保健相关的产品和服务的支出，例如处方药、住院、就诊、医疗设备和公共卫生工作。医疗保健支出的成长将受到微创手术、先进的诊断技术、新药研发的增加、医疗保健服务利用率的提高以及专科药物的使用等因素的推动。增加医疗保健支出将提供充分利用 COVID-19 唾液筛检测试潜力所需的资源，从而实现更有效的疫情管理并改善公共卫生结果。例如，根据英国国家统计局的数据，2022年英国的医疗保健支出将达到约3,548.8亿美元（2,830亿英镑），与2021年相比略有增加0.7%。因此，医疗保健支出的增加正在推动COVID-19唾液筛检测试市场的成长。

COVID-19 唾液筛检检测市场的关键参与者正专注于开发资料共用平台等创新技术，以改善医疗保健提供者、实验室和公共卫生当局之间的即时沟通和协作。这将提高疫情期间侦测、追踪和应对工作的效率和准确性。资料共用平台是一种数位系统，可实现医疗保健提供者、研究人员和组织等各相关人员之间的安全资料交换。促进合作并方便获取信息，以改善跨部门的决策、效率和成果。例如，2024年5月，美国医疗保健网路西奈山医疗系统推出了医疗保健准备中心。该中心将致力于加强公共卫生紧急应变策略，以确保卫生保健系统能够有效应对流行病和自然灾害等大规模危机。该中心旨在加强西奈山医疗系统与当地和联邦合作伙伴制定全面紧急计画的能力。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场－宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球COVID-19唾液筛检检测潜力PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球 COVID-19 唾液筛检检测市场潜力：成长率分析
• 全球 COVID-19 唾液筛检检测市场潜力：规模与成长，2019-2024 年
• 全球 COVID-19 唾液筛检检测市场潜力预测：规模与成长，2024-2029 年，2034 年
• 全球 COVID-19 唾液筛检测试总目标市场 (TAM)

第六章市场区隔

• 全球 COVID-19 唾液筛检检测市场潜力（按地区、实际情况及预测），2019-2024 年、2024-2029 年、2034 年
• 旅行站
• 体育馆
• 娱乐场所
• 企业园区环境
• 大学和学院
• 工厂
• 其他地点
• 全球 COVID-19 唾液筛检检测市场潜力（依技术、历史资料及预测），2019-2024 年、2024-2029 年、2034 年
• 萤光标记抗原
• RT-PCR
• CRISPR-Cas9
• 全球 COVID-19 唾液筛检检测市场潜力（依检测模式、实际状况及预测），2019-2024 年、2024-2029 年、2034 年
• 重点测试
• 分散式测试
• 全球 COVID-19 唾液筛检检测潜在市场，依旅游站类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 飞机场
• 火车站
• 客运站
• 港口
• 全球 COVID-19 唾液筛检测试潜在市场细分（按体育场馆类型、实际和预测），2019-2024 年、2024-2029 年、2034 年
• 体育场
• 竞技场
• 活动大厅
• 全球 COVID-19 唾液筛检测试潜在市场细分（按娱乐场所类型、实际情况和预测），2019-2024 年、2024-2029 年、2034 年
• 剧院
• 音乐厅
• 游乐园
• 夜总会
• 全球 COVID-19 唾液筛检检测潜在市场细分（按公司类型、校园环境、实际情况和预测），2019-2024 年、2024-2029 年、2034 年
• 办公室
• 企业园区
• 商业园区
• 全球 COVID-19 唾液筛检检测潜在市场细分（按大学类型、实际情况和预测），2019-2024 年、2024-2029 年、2034 年
• 高等教育园区
• 研究机构
• 宿舍区
• 全球 COVID-19 唾液筛检测试潜在市场细分（按工厂类型、实际情况和预测），2019-2024 年、2024-2029 年、2034 年
• 製造工厂
• 生产设施
• 工业用地
• 全球 COVID-19 唾液筛检测试潜在市场、世界其他地区细分市场、按类型、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 医疗保健设施
• 政府大楼
• 公共运输枢纽
• 购物中心
• 其他公共或私人场所

第七章 区域和国家分析

• 全球 COVID-19 唾液筛检检测潜在市场（按地区、现况及预测）2019-2024 年、2024-2029 年、2034 年
• 全球 COVID-19 唾液筛检检测潜在市场：按国家/地区划分、现状及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• COVID-19 唾液筛检测试的潜在市场：竞争格局
• COVID-19 唾液筛检测试的潜在市场：公司简介
  • Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• University of North Carolina at Chapel Hill
• Hologic Inc.
• Beaumont Health
• PerkinElmer Inc.
• Quidel Corporation
• University of Illinois at Urbana-Champaign
• Cepheid
• Seegene Inc.
• ARUP Laboratories
• Vatic Health Limited
• Ambry Genetics Corporation
• LumiraDx Ltd.
• Yale School of Public Health
• Gravity Diagnostics
• Psomagen Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年 COVID-19 唾液筛检检测市场潜力：提供新机会的国家
• 2029 年 COVID-19 唾液筛检检测市场潜力：细分市场带来新机会
• COVID-19 唾液筛检检测市场潜力（2029 年）：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

The potential of saliva-based COVID-19 screening tests pertains to the possible benefits and capabilities they offer in comparison to conventional methods such as nasopharyngeal or oropharyngeal swab tests for detecting the SARS-CoV-2 virus, which causes COVID-19. This potential encompasses enhancements in testing accessibility, patient acceptance, cost-effectiveness, and safety, while also facilitating the adoption of new testing strategies and approaches for better management of the pandemic.

Key locations where the potential of COVID-19 saliva screening tests is prominent include travel stations, sports arenas, entertainment venues, corporate campuses, universities and colleges, factories, and similar settings. Travel stations are specifically designated areas within transportation hubs where individuals can undergo COVID-19 saliva screening tests before commencing their journeys. These tests utilize various technologies such as fluorescence-labeled antigen, rt-PCR, and CRISPR-Cas9, with testing conducted through centralized or decentralized approaches.

The COVID-19 saliva screening test potential market research report is one of a series of new reports from The Business Research Company that provides COVID-19 saliva screening test potential market statistics, including COVID-19 saliva screening test potential industry global market size, regional shares, competitors with a COVID-19 saliva screening test potential market share, detailed COVID-19 saliva screening test potential market segments, market trends, and opportunities, and any further data you may need to thrive in the COVID-19 saliva screening test potential industry. This COVID-19 saliva screening test potential market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The COVID-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.9 billion in 2024 to $4.29 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to the potential for home testing, unprecedented need for diagnostic testing, rise in public awareness, and research and development investment.

The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $6.17 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to integration with screening programs, regulatory support, growing demand for speedy, point-of-care COVID-19 tests, increasing population, and the rise of e-commerce. Major trends in the forecast period include increasing adoption in non-healthcare settings, integration with digital health platforms, emergence of next-generation technologies, technological advancements, and strategic partnerships.

The growing healthcare expenditure is expected to drive the expansion of the COVID-19 saliva screening test market in the coming years. Healthcare expenditure includes all spending on healthcare-related products and services, such as prescription medications, hospital stays, doctor visits, medical equipment, and public health initiatives. The rise in healthcare expenditure is driven by factors like minimally invasive surgeries, advanced diagnostic technologies, increased research and development for new drugs, greater utilization of healthcare services, and the use of specialty medications. Higher healthcare spending provides the resources needed to fully leverage the potential of COVID-19 saliva screening tests, leading to more effective pandemic management and improved public health outcomes. For example, in 2022, according to the Office for National Statistics, the UK's healthcare expenditure reached around $354.88 billion (£283 billion), marking a slight increase of 0.7% compared to 2021. Therefore, the increase in healthcare expenditure is fueling the growth of the COVID-19 saliva screening test market.

Key players in the COVID-19 saliva screening test market are focusing on developing innovative technologies, such as data-sharing platforms, to improve real-time communication and collaboration among healthcare providers, laboratories, and public health authorities. This helps enhance the efficiency and accuracy of testing, tracking, and response efforts during the pandemic. Data-sharing platforms are digital systems that enable secure data exchange between various stakeholders, including healthcare providers, researchers, and organizations. They promote collaboration and facilitate access to information, thereby improving decision-making, efficiency, and outcomes across sectors. For example, in May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. The Center is focused on enhancing strategies for public health emergency response, ensuring that healthcare systems can effectively manage large-scale crises, such as pandemics or natural disasters. It aims to strengthen the capacity of the Mount Sinai Health System and work with local, regional, and federal partners to develop comprehensive preparedness plans.

In July 2024, Hologic, Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. Through this acquisition, Hologic, Inc. aims to broaden its portfolio of innovative healthcare solutions and expand its presence in the women's health market. Endomagnetics Ltd. is a UK-based medical technology company that develops devices designed to detect cancerous lymph nodes during surgery.

Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.

North America was the largest region in the COVID-19 saliva screening test potential market in 2024. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the COVID-19 saliva screening test potential market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The COVID-19 saliva screening test potential market consist revenues earned by entities by providing services such as sample collection services, laboratory testing services, diagnostic reporting services, and screening and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 saliva screening test potential market also consists of sales of saliva collection kits, rapid saliva testing kits, laboratory testing supplies, and automated sample processing systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

COVID-19 Saliva Screening Test Potential Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on covid-19 saliva screening test potential market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for covid-19 saliva screening test potential ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The covid-19 saliva screening test potential market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Location: Travel Stations; Sports Arenas; Entertainment Venues; Corporate Campus Environments; Universities And Colleges; Factories; Other Locations
• 2) By Technology: Fluorescence-Labelled Antigen; RT-PCR; CRISPR-Cas9
• 3) By Mode Of Testing: Centralized Testing; Decentralized Testing
• Subsegments:
• 1) By Travel Stations: Airports; Train Stations; Bus Stations; Seaports
• 2) By Sports Arenas: Stadiums; Arenas; Event Halls
• 3) By Entertainment Venues: Theaters; Concert Halls; Amusement Parks; Nightclubs
• 4) By Corporate Campus Environments: Offices; Corporate Campuses; Business Parks
• 5) By Universities And Colleges: Higher Education Campuses; Research Institutions; Student Housing Areas
• 6) By Factories: Manufacturing Plants; Production Facilities; Industrial Sites
• 7) By Other Locations: Healthcare Facilities; Government Buildings; Public Transportation Hubs; Shopping Centers; Other Public Or Private Venues
• Companies Mentioned: Roche Diagnostics Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson and Company; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. COVID-19 Saliva Screening Test Potential market Characteristics

3. COVID-19 Saliva Screening Test Potential market Trends And Strategies

4. COVID-19 Saliva Screening Test Potential market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global COVID-19 Saliva Screening Test Potential Growth Analysis And Strategic Analysis Framework

• 5.1. Global COVID-19 Saliva Screening Test Potential PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global COVID-19 Saliva Screening Test Potential market Growth Rate Analysis
• 5.4. Global COVID-19 Saliva Screening Test Potential Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global COVID-19 Saliva Screening Test Potential Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global COVID-19 Saliva Screening Test Potential Total Addressable Market (TAM)

6. COVID-19 Saliva Screening Test Potential market Segmentation

• 6.1. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Travel Stations
• Sports Arenas
• Entertainment Venues
• Corporate Campus Environments
• Universities And Colleges
• Factories
• Other Locations
• 6.2. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluorescence-Labelled Antigen
• RT-PCR
• CRISPR-Cas9
• 6.3. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Centralized Testing
• Decentralized Testing
• 6.4. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Travel Stations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Airports
• Train Stations
• Bus Stations
• Seaports
• 6.5. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Sports Arenas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stadiums
• Arenas
• Event Halls
• 6.6. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Entertainment Venues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Theaters
• Concert Halls
• Amusement Parks
• Nightclubs
• 6.7. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Corporate Campus Environments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Offices
• Corporate Campuses
• Business Parks
• 6.8. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Universities And Colleges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Higher Education Campuses
• Research Institutions
• Student Housing Areas
• 6.9. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Factories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manufacturing Plants
• Production Facilities
• Industrial Sites
• 6.10. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Other Locations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Healthcare Facilities
• Government Buildings
• Public Transportation Hubs
• Shopping Centers
• Other Public Or Private Venues

7. COVID-19 Saliva Screening Test Potential market Regional And Country Analysis

• 7.1. Global COVID-19 Saliva Screening Test Potential market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global COVID-19 Saliva Screening Test Potential market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific COVID-19 Saliva Screening Test Potential market

• 8.1. Asia-Pacific COVID-19 Saliva Screening Test Potential market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China COVID-19 Saliva Screening Test Potential market

• 9.1. China COVID-19 Saliva Screening Test Potential market Overview
• 9.2. China COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India COVID-19 Saliva Screening Test Potential market

• 10.1. India COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan COVID-19 Saliva Screening Test Potential market

• 11.1. Japan COVID-19 Saliva Screening Test Potential market Overview
• 11.2. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia COVID-19 Saliva Screening Test Potential market

• 12.1. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia COVID-19 Saliva Screening Test Potential market

• 13.1. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea COVID-19 Saliva Screening Test Potential market

• 14.1. South Korea COVID-19 Saliva Screening Test Potential market Overview
• 14.2. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe COVID-19 Saliva Screening Test Potential market

• 15.1. Western Europe COVID-19 Saliva Screening Test Potential market Overview
• 15.2. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK COVID-19 Saliva Screening Test Potential market

• 16.1. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany COVID-19 Saliva Screening Test Potential market

• 17.1. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France COVID-19 Saliva Screening Test Potential market

• 18.1. France COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy COVID-19 Saliva Screening Test Potential market

• 19.1. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain COVID-19 Saliva Screening Test Potential market

• 20.1. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe COVID-19 Saliva Screening Test Potential market

• 21.1. Eastern Europe COVID-19 Saliva Screening Test Potential market Overview
• 21.2. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia COVID-19 Saliva Screening Test Potential market

• 22.1. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America COVID-19 Saliva Screening Test Potential market

• 23.1. North America COVID-19 Saliva Screening Test Potential market Overview
• 23.2. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA COVID-19 Saliva Screening Test Potential market

• 24.1. USA COVID-19 Saliva Screening Test Potential market Overview
• 24.2. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada COVID-19 Saliva Screening Test Potential market

• 25.1. Canada COVID-19 Saliva Screening Test Potential market Overview
• 25.2. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America COVID-19 Saliva Screening Test Potential market

• 26.1. South America COVID-19 Saliva Screening Test Potential market Overview
• 26.2. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil COVID-19 Saliva Screening Test Potential market

• 27.1. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East COVID-19 Saliva Screening Test Potential market

• 28.1. Middle East COVID-19 Saliva Screening Test Potential market Overview
• 28.2. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa COVID-19 Saliva Screening Test Potential market

• 29.1. Africa COVID-19 Saliva Screening Test Potential market Overview
• 29.2. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. COVID-19 Saliva Screening Test Potential market Competitive Landscape And Company Profiles

• 30.1. COVID-19 Saliva Screening Test Potential market Competitive Landscape
• 30.2. COVID-19 Saliva Screening Test Potential market Company Profiles
  • 30.2.1. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. COVID-19 Saliva Screening Test Potential market Other Major And Innovative Companies

• 31.1. University of North Carolina at Chapel Hill
• 31.2. Hologic Inc.
• 31.3. Beaumont Health
• 31.4. PerkinElmer Inc.
• 31.5. Quidel Corporation
• 31.6. University of Illinois at Urbana-Champaign
• 31.7. Cepheid
• 31.8. Seegene Inc.
• 31.9. ARUP Laboratories
• 31.10. Vatic Health Limited
• 31.11. Ambry Genetics Corporation
• 31.12. LumiraDx Ltd.
• 31.13. Yale School of Public Health
• 31.14. Gravity Diagnostics
• 31.15. Psomagen Inc.

32. Global COVID-19 Saliva Screening Test Potential market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential market

34. Recent Developments In The COVID-19 Saliva Screening Test Potential market

35. COVID-19 Saliva Screening Test Potential market High Potential Countries, Segments and Strategies

• 35.1 COVID-19 Saliva Screening Test Potential market In 2029 - Countries Offering Most New Opportunities
• 35.2 COVID-19 Saliva Screening Test Potential market In 2029 - Segments Offering Most New Opportunities
• 35.3 COVID-19 Saliva Screening Test Potential market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer